FDA inspection
NanChang Anobri Pharmaceutical Co., Ltd.: FDA inspection ending Nov 21, 2023
FDA inspection 1226722 · Official Action Indicated (OAI) · Nanchang
Key facts
| Inspection ID | 1226722 |
|---|---|
| Firm | NanChang Anobri Pharmaceutical Co., Ltd. |
| FEI number | 3023765884 |
| Address | Nanchang Economic & Technological Dev., Bldg. B1 ; 888 Jingkai Avenue; Jiangxi Nanchang Xiao Lan Jingjijizhukaifa Nanchangxian |
| City | Nanchang |
| Fiscal year | 2024 |
| Inspection end date | Nov 21, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data